profit from every $100 of sales.
$0$100
Mobia Medical
$13.47+10.41% today
-10.2% since May 6, 26
1-year low $8.091-year high $15.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2024 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Mobia Medical sold, what it kept, and what it did with the cash.
Sales went from $15.6 million in 2024 to $32.0 million in 2025, with -$46.5 million of profit last year.
SalesProfit
Mobia Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Mobia Medical | No profit yet | ||
 Ekso Bionics Holdings | No profit yet | ||
 Takara Bio | 130.9× · Very expensive | ||
 Shoulder Innovations | No profit yet | ||
 Edap Tms | No profit yet |
AI analysis
An AI analyst reads Mobia Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2024 | 2025 |
|---|---|---|
| 16 | 32 | |
| 12 | 26 | |
| -24 | -46 | |
| -24 | -45 | |
| -25 | -46 | |
| -1.08 | – | |
| 79.6% | 81.1% | |
| -154.9% | -144.7% | |
| -157.3% | -145.1% |
Balance sheet
| In millions of USD | 2024 | 2025 |
|---|---|---|
| Total assets | 22 | 48 |
| Cash | 15 | 34 |
| Total debt | 8 | 8 |
| Total liabilities | 128 | 199 |
| -106 | -151 | |
| 23 | – | |
| – | – | |
| 23.2% | 30.8% |
Cash flow
| In millions of USD | 2024 | 2025 |
|---|---|---|
| -24 | -46 | |
| 0 | 0 | |
| -24 | -46 | |
| Dividends paid | – | – |
| – | – | |
| 1 | 1 |
Valuation
- –
- –
- –
- –
- 14.0×
- –
- –
- -10.3%
- -10.4%
- –
Profitability
- 81.1%
- -144.7%
- -145.1%
- –
- –
- –
- –
- –
- –
- –
Growth
- +104.8%
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 2%of 889
Top 5%of 890
Bottom 10%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Mobia Medical
Is Mobia Medical a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Mobia Medical AI analysis
What does Mobia Medical do?
Mobia Medical, Inc. operates as a commercial-stage medical device company. It engages in developing solutions for stroke recovery survivors with motor impairments. It is in Medical - Specialties.
Does Mobia Medical pay a dividend?
No. Mobia Medical does not pay a dividend at the moment.
Is Mobia Medical stock halal?
Yes. Mobia Medical passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
Who are Mobia Medical's competitors?
The largest listed companies in the same industry are Ekso Bionics Holdings, Takara Bio, Shoulder Innovations and Edap Tms. The peers table on this page compares their profit, growth and price with Mobia Medical's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.